Loading company…
Angiocrine Bioscience
PrivateWon 2 federal SBIR/STTR research awards from HHS and other federal agencies.
Department of Health and Human ServicesNational Institutes of Health
- SAM UEI
- F6V8JNZZG6E6
- Founded
- —Source: [GOV]
- Headquarters
- New York, New YorkSource: [GOV]
- Headcount
- 8Source: [GOV]
- Stage
- Seed
- Sector
- Healthcare
$0Source: [GOV]Total raised
UndisclosedSource: [GOV]Last valuation
Overview
Angiocrine Bioscience has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $374,594 in 2015. These are non-dilutive federal research grants, not equity financing. The company is based in New York, New York.
Funding rounds
2 rounds- SBIR Phase I award (HHS)GrantJan 2015Source: [GOV]$189.1K—post-money
- SBIR Phase I award (HHS)
Investors
No investors recorded yet for Angiocrine Bioscience.
Add an investorPeople
LeadershipAcquisitions
Angiocrine Bioscience has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for Angiocrine Bioscience.
Add diversity data